v3.26.1
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Total revenue $ 132,865 $ 3,120
Costs and expenses:    
Research and development 12,571 6,966
Selling, general and administrative 46,938 30,062
Total costs and expenses 71,361 38,545
Income (loss) from operations 61,504 (35,425)
Other income (expense):    
Interest income 1,772 1,728
Interest expense (6,494) (4,670)
Total other expense, net (4,722) (2,942)
Income (loss) before income taxes 56,782 (38,367)
Income tax expense 3,920 0
Net income (loss) and comprehensive income (loss) $ 52,862 $ (38,367)
Net income (loss) per common share, basic (in dollars per share) $ 0.6 $ (0.45)
Net income (loss) per common share, diluted (in dollars per share) $ 0.52 $ (0.45)
Weighted average common shares outstanding, basic (in shares) 88,006,244 85,172,696
Weighted average common shares outstanding, diluted (in shares) 101,112,095 85,172,696
Product sales, net    
Total revenue $ 129,881  
Costs and expenses:    
Cost of revenue 11,079  
Service revenue, net    
Total revenue 2,984 $ 3,120
Costs and expenses:    
Cost of revenue $ 773 $ 1,517